170 related articles for article (PubMed ID: 3435078)
1. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
Mesulam MM; Geula C; Morán MA
Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
[TBL] [Abstract][Full Text] [Related]
2. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
Geula C; Mesulam M
Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of Alzheimer's disease. Evaluation of senile plaques of the diffuse type].
Morán MA; Cebrián JL; Gómez-Ramos P; Cabello A; Madero S; Mufson EJ
Med Clin (Barc); 1992 Jan; 98(1):19-23. PubMed ID: 1545606
[TBL] [Abstract][Full Text] [Related]
4. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR
Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555
[TBL] [Abstract][Full Text] [Related]
5. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC
Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444
[TBL] [Abstract][Full Text] [Related]
6. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
Volger BW
Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases in the amyloid angiopathy of Alzheimer's disease.
Mesulam M; Carson K; Price B; Geula C
Ann Neurol; 1992 May; 31(5):565-9. PubMed ID: 1375822
[TBL] [Abstract][Full Text] [Related]
8. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
[TBL] [Abstract][Full Text] [Related]
9. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
Shortridge BA; Vogel FS; Burger PC
Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
[TBL] [Abstract][Full Text] [Related]
10. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
Schätz CR; Geula C; Mesulam M
Neurosci Lett; 1990 Sep; 117(1-2):56-61. PubMed ID: 2290622
[TBL] [Abstract][Full Text] [Related]
11. Effects of 9-amino-1,2,3,4-tetrahydroacridine (THA), a potential drug for treatment of Alzheimer's disease, on the physical state of human erythrocyte membranes.
Palmieri DA; Butterfield DA
Prog Clin Biol Res; 1989; 292():419-24. PubMed ID: 2726917
[No Abstract] [Full Text] [Related]
12. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
Marquis JK
Biochem Pharmacol; 1990 Sep; 40(5):1071-6. PubMed ID: 2390104
[TBL] [Abstract][Full Text] [Related]
13. Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.
Hallak M; Giacobini E
Neuropharmacology; 1989 Mar; 28(3):199-206. PubMed ID: 2725846
[TBL] [Abstract][Full Text] [Related]
14. [Histochemical representation of acetylcholinesterase in Alzheimer's disease].
Ulrich J
Acta Histochem Suppl; 1992; 42():11-2. PubMed ID: 1374916
[TBL] [Abstract][Full Text] [Related]
15. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators].
Burov IuV; Baĭmanov TD; Maĭsov NI
Biull Eksp Biol Med; 1992 Apr; 113(4):379-81. PubMed ID: 1356507
[TBL] [Abstract][Full Text] [Related]
16. Shifting patterns of cortical cholinesterases in Alzheimer's disease: implications for treatment, diagnosis, and pathogenesis.
Mesulam MM; Geula C
Adv Neurol; 1990; 51():235-40. PubMed ID: 2403715
[No Abstract] [Full Text] [Related]
17. Protease nexin I immunostaining in Alzheimer's disease.
Rosenblatt DE; Geula C; Mesulam MM
Ann Neurol; 1989 Nov; 26(5):628-34. PubMed ID: 2554792
[TBL] [Abstract][Full Text] [Related]
18. Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro.
Perry EK; Smith CJ; Court JA; Bonham JR; Rodway M; Atack JR
Neurosci Lett; 1988 Aug; 91(2):211-6. PubMed ID: 3185960
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease.
Kumar V; Becker RE
Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):478-85. PubMed ID: 2684868
[TBL] [Abstract][Full Text] [Related]
20. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Coleman AE; Geula C; Price BH; Mesulam MM
Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
